Premium
[O1–14–02]: A NOVEL DISCOIDIN DOMAIN RECEPTOR INHIBITOR REDUCES NEUROPATHOLOGY AND ATTENUATES INFLAMMATION IN ALZHEIMER AND PARKINSON MODELS
Author(s) -
EH Moussa Charbel,
Hebron Michaeline,
Lonskaya Irina
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.114
Subject(s) - discoidin domain , ddr1 , neurodegeneration , gene knockdown , neuropathology , inflammation , receptor , memantine , receptor tyrosine kinase , biology , cancer research , microbiology and biotechnology , pharmacology , neuroscience , chemistry , kinase , medicine , disease , immunology , biochemistry , gene , nmda receptor